Methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate
C32H23FN6O5 — CID 146638819
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate
Methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate (PubChem CID 146638819) has the molecular formula C32H23FN6O5 and a molecular weight of 590.57 g/mol. Its IUPAC name is methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate.
Molecular Properties
| Compound Name | Methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate |
|---|---|
| PubChem CID | 146638819 |
| Molecular Formula | C32H23FN6O5 |
| Molecular Weight | 590.57 g/mol |
| Exact Mass | 590.17 |
| IUPAC Name | methyl 2-[6-[(1S)-1-[2-(1,3-dioxoisoindol-2-yl)-6-fluoroquinolin-3-yl]oxyethyl]-5-pyrazol-1-ylindazol-1-yl]acetate |
| SMILES | COC(=O)Cn1ncc2cc(-n3cccn3)c([C@H](C)Oc3cc4cc(F)ccc4nc3N3C(=O)c4ccccc4C3=O)cc21 |
| InChI | InChI=1S/C32H23FN6O5/c1-18(24-15-26-20(13-27(24)37-11-5-10-34-37)16-35-38(26)17-29(40)43-2)44-28-14-19-12-21(33)8-9-25(19)36-30(28)39-31(41)22-6-3-4-7-23(22)32(39)42/h3-16,18H,17H2,1-2H3/t18-/m0/s1 |
| InChIKey | RPHGZFSJUHPPIZ-SFHVURJKSA-N |
| XLogP | 5.02 |
| TPSA | 121.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 590.57 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146638819 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.